
The latest from our team in @JAMAInternalMed In people with type 2 diabetes on metformin, adding SGLT2i was associated with reduced mortality compared to sulfonylureas. @VAResearch @vahsrd @WUSTLpubhealth @VREFSTL @VASTLResearch @Biostayan @WUSTLendo jamanetwork.com/journals/jam…

















